CORONARY INTERVENTIONS

A randomised comparison of biodegradable polymer- and permanent polymer-coated platinum-chromium everolimus-eluting coronary stents in China: the EVOLVE China study

EuroIntervention 2017;13:1210-1217 published online July 2017. DOI: 10.4244/EIJ-D-17-00271

Yaling Han1*, MD, PhD; Haiwei Liu1, MD; Yuejin Yang2, MD; Jian Zhang3, MD; Kai Xu1, MD; Guosheng Fu4, MD; Xi Su5, MD; Tiemin Jiang6, MD; Wenyue Pang7, MD, PhD; Jiyan Chen8, MD, PhD; Zuyi Yuan9, MD; Hui Li10, MD; Haichang Wang11, MD; Tao Hong12, MD; Huiliang Liu13, MD; Fucheng Sun14, MD; Dominic J. Allocco15, MD; Mingdong Zhang15, MD, PhD; Keith D. Dawkins15, MD

1. General Hospital of Shenyang Military Region, Shenyang, China; 2. Cardiovascular Institute and Fu Wai Hospital, Beijing, China; 3. TEDA International Cardiovascular Hospital, Tianjin, China; 4. Sir Run Run Shaw Hospital, School of Medicine, Zhejiang Un

Aims: The EVOLVE China randomised study sought to evaluate the clinical safety and effectiveness of the SYNERGY bioabsorbable polymer-coated everolimus-eluting stent (EES) for the treatme

Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

clinical trialscoronary artery diseaseclinical research

Share on Facebook Share on Twitter Share on Linkedin